Skip to content

Short-term effectiveness of Honeysuckle probiotic toothpaste for treating recurrent aphthous ulcers: A randomized, double-blind, placebo-controlled clinical trial.

The clinical efficacy of honeysuckle probiotic toothpaste in controlling dental plaque, reducing gum inflammation, and treating recurrent aphthous ulcers.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088965
Enrollment
Unknown
Registered
2024-08-29
Start date
2023-10-30
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Aphthous Ulcer

Interventions

The experimental group:Using toothpaste containing honeysuckle extract (fermented by probiotics)
The control group:Using toothpaste without honeysuckle extract (all other ingredients are the same except for honeysuckle extract)

Sponsors

Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Good overall health status with no significant systemic diseases; (2) Aged 20 to 60 years; (3) If female, not pregnant or breastfeeding; (4) Diagnosed with recurrent aphthous ulcers with an onset within the past 48 hours and no previous treatment; (5) Provide informed consent and be able to complete clinical trials as required.

Exclusion criteria

Exclusion criteria: (1) Allergies to the investigational toothpaste ingredients; (2) Individuals who have used analgesics or vitamins within 24 hours, antibiotics within 1 month, and systemic corticosteroids or immunomodulators within 3 months prior to participating in the study; (3) Severe aphthous ulcers, herpetic aphthous ulcers, acute herpetic gingivostomatitis, traumatic ulcers, cancerous ulcers, tuberculous ulcers, syphilitic ulcers, necrotizing sialometaplasia, Behçet's disease, and ulcers caused by other diseases or medications; (4) Suspected or confirmed history of alcohol or drug abuse; (5) Individuals currently participating in or planning to participate in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Total score of ulcer status ;Ulcer healing rate;

Secondary

MeasureTime frame
Ulcer number score ;Ulcer size score ;Ulcer hyperemia score ;Ulcer pain score;Ulcer burning sensation score ;Average ulcer duration score;

Countries

China

Contacts

Public ContactJijia Li

Xiangya Hospital, Central South University

lijijia1986@126.com+86 139 7581 1145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026